External resources SURMOUNT-1 clinical trial results (New England Journal of Medicine) NIH National Institute of Diabetes and Digestive and Kidney Diseases In case I do not see you, good afternoon, good evening, and good night
In 2024 Blue Cross Blue Shield of Michigan informed members and physicians about a change in coverage for GLP-1s.On the surface, GLP-1s promise weight loss, lower blood pressure and a reduced risk of heart and kidney disease, according to the Cleveland Clinic
Reviewing your daily skincare regimens ingredients helps ensure youre not using multiple copper peptide products simultaneously
Telehealth platform Hims & Hers has teamed up with a drug manufacturer to produce generic, low-cost versions of Ozempic and Wegovy, which contain the same active ingredient (semaglutide) as the market-leading drugs, but circumvent the frequent shortages and sky-high prices
This blog explores the potential of sleep peptides like DSIP and Sermorelin to improve sleep quality and recovery